Proteomics

Dataset Information

Proteomics and system biology identify an antitumoral signature following allogeneic donor lymphocyte injection


ABSTRACT: A protein signature that could identify graft-versus-tumor (GVT) activity without graft-versus-host disease (GVHD), would allow for customized treatment plans following hematopoietic cell transplantation (HCT). Using orthogonal three-dimensional intact-protein analysis system (IPAS) coupled with protein tagging and novel systems biology pipeline, we identified a signature of 49 proteins that are significantly increased in the plasma of HCT patients who received donor lymphocyte injection for tumor relapse and develop GVT without GVHD.

INSTRUMENT(S): LTQ

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Sophie Paczesney  

PROVIDER: MSV000081057 | MassIVE | Wed May 03 14:35:00 BST 2017

REPOSITORIES: MassIVE